Partner David Rosen was quoted in an Inside Health Policy article on January 22, 2014 titled “Generic Drug Industry Prioritizes Challenge to New Labeling Rule in 2014.” The article discusses the top priority for the generic drug industry in 2014 which will be combating a new regulation aimed at requiring generic drugmakers to make labeling changes to reflect new safety information. Rosen was quoted saying, “I think it’s going to be a pretty big deal.”
People
Related News
July 11, 2025
In the News
David Morris Featured for Arrival to Foley's Salt Lake City Office
Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.
July 10, 2025
In the News
Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment
Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."
July 7, 2025
In the News
Louis Lehot Assesses Deal Trends in Shifting Market
Foley & Lardner LLP partner Louis Lehot assessed dealmaking trends in the Law360 article, "PE Dealmakers Best-Suited To Cut Through M&A Challenges."